|
|
|
Volumn 81, Issue 16, 2013, Pages 1474-1475
|
|
Evidence-based guideline: Treatment of parenchymal neurocysticercosis: report of the Guideline Development Subcommittee of the American Academy of Neurology.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALBENDAZOLE;
ANTICESTODAL AGENT;
EVIDENCE BASED MEDICINE;
FEMALE;
HUMAN;
MALE;
NEUROCYSTICERCOSIS;
NEUROLOGY;
NOTE;
ORGANIZATION;
STANDARD;
STANDARDS;
ACADEMIES AND INSTITUTES;
ALBENDAZOLE;
ANTICESTODAL AGENTS;
EVIDENCE-BASED MEDICINE;
FEMALE;
HUMANS;
MALE;
NEUROCYSTICERCOSIS;
NEUROLOGY;
|
|
EID: 84900211324
PISSN: None
EISSN: 1526632X
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
